EnSite Precision Cardiac Mapping System
Device
Abbott Laboratories
Total Payments
$2.8M
Transactions
8,830
Doctors
2,286
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $2.6M | 8,563 | 2,256 |
| 2020 | $192,929 | 198 | 41 |
| 2019 | $11,625 | 69 | 11 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.2M | 228 | 43.6% |
| Consulting Fee | $662,718 | 430 | 23.9% |
| Food and Beverage | $306,370 | 6,575 | 11.0% |
| Travel and Lodging | $236,847 | 758 | 8.5% |
| Compensation for serving as faculty or as a speaker for a medical education program | $191,311 | 227 | 6.9% |
| Education | $108,720 | 598 | 3.9% |
| Space rental or facility fees (teaching hospital only) | $51,064 | 9 | 1.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,850 | 5 | 0.3% |
Payments by Type
General
$1.6M
8,602 transactions
Research
$1.2M
228 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| TactiFlex IDE | Abbott Laboratories | $816,974 | 0 |
| A Clinical Evaluation using EnSite Precision Cardiac Mapping System (software version 2.0.1 or higher) in a Real-World Environment | Abbott Laboratories | $110,205 | 0 |
| FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of VT | Abbott Laboratories | $99,041 | 0 |
| Implantation of the HeartMate 3 in Subjects with Heart Failure using Surgical Techniques Other Than Full Median Sternotomy | Abbott Laboratories | $71,634 | 0 |
| LSI (Lesion Index) Workflow Post-Market Observational Study | Abbott Laboratories | $41,719 | 0 |
| Mapping and Pacing of the His Bundle for Heart Failure Patients with Left Bundle Branch Block | Abbott Laboratories | $29,670 | 0 |
| Mapping and Pacing of the His Bundle for Heart Failure Patients With Left Bundle Branch Block (MAP HIS HF) | Abbott Laboratories | $17,562 | 0 |
| DYNAMIC-AF | Abbott Laboratories | $12,500 | 0 |
| MAP HIS HF Study CRD969 10253 | Abbott Laboratories | $5,043 | 0 |
| Advanced Maps Research Consortium | Abbott Laboratories | $5,000 | 1 |
| TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study | Abbott Laboratories | $705.00 | 0 |
| Prospective, multicenter, post-market, single-arm, observational study | Abbott Laboratories | $500.00 | 0 |
| Safety and Effectiveness of TactiCath Contact Force, Sensor Enabled (TactiCath SE) Catheter for Ablation of Drug Refractory, Symptomatic, Persistent Atrial Fibrillation (PERSIST-END Trial) | Abbott Laboratories | $450.00 | 0 |
Top Doctors Receiving Payments for EnSite Precision Cardiac Mapping System
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | New York, NY | $1.3M | 245 |
| , M.D | Clinical Cardiac Electrophysiology | Chicago, IL | $57,989 | 35 |
| , M.D | Clinical Cardiac Electrophysiology | Littleton, CO | $43,458 | 60 |
| , M.D | Clinical Cardiac Electrophysiology | Philadelphia, PA | $31,372 | 25 |
| , M.D | Cardiovascular Disease | Charlotte, NC | $29,626 | 67 |
| , MD | Clinical Cardiac Electrophysiology | Chicago, IL | $26,665 | 27 |
| , M.D, | Cardiovascular Disease | Los Angeles, CA | $22,861 | 18 |
| , M.D., M.A | Cardiovascular Disease | Overland Park, KS | $22,814 | 37 |
| , M.D | Clinical Cardiac Electrophysiology | Minneapolis, MN | $22,785 | 10 |
| , MBBS | Cardiovascular Disease | Minneapolis, MN | $22,581 | 8 |
| , MD | Cardiovascular Disease | Greenville, SC | $22,423 | 30 |
| , MD | Clinical Cardiac Electrophysiology | San Diego, CA | $21,947 | 26 |
| , M.D | Internal Medicine | Aurora, CO | $20,841 | 38 |
| , MD PHD | Clinical Cardiac Electrophysiology | Boston, MA | $17,547 | 25 |
| , MD | Cardiovascular Disease | Philadelphia, PA | $16,899 | 12 |
| , MD | Specialist | Austin, TX | $16,430 | 50 |
| , M.D | Cardiovascular Disease | Chicago, IL | $15,555 | 31 |
| , M.D | Cardiovascular Disease | Rochester, MN | $15,438 | 18 |
| , MD | Clinical Cardiac Electrophysiology | Little Rock, AR | $15,100 | 42 |
| , M.D | Cardiovascular Disease | Dallas, TX | $14,346 | 33 |
| , MD | Cardiovascular Disease | Las Vegas, NV | $13,695 | 27 |
| , MD | Clinical Cardiac Electrophysiology | Nashville, TN | $13,417 | 30 |
| , MD | Clinical Cardiac Electrophysiology | Brookline, MA | $12,837 | 29 |
| , MD | Cardiovascular Disease | New York, NY | $12,410 | 14 |
| , MD | Cardiovascular Disease | Houston, TX | $11,662 | 10 |
Ad
Manufacturing Companies
- Abbott Laboratories $2.8M
Product Information
- Type Device
- Total Payments $2.8M
- Total Doctors 2,286
- Transactions 8,830
About EnSite Precision Cardiac Mapping System
EnSite Precision Cardiac Mapping System is a device associated with $2.8M in payments to 2,286 healthcare providers, recorded across 8,830 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2019 to 2021. In 2021, $2.6M was paid across 8,563 transactions to 2,256 doctors.
The most common payment nature for EnSite Precision Cardiac Mapping System is "Unspecified" ($1.2M, 43.6% of total).
EnSite Precision Cardiac Mapping System is associated with 13 research studies, including "TactiFlex IDE" ($816,974).